학술논문
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study
Document Type
Article
Author
Orkin, Chloe; DeJesus, Edwin; Ramgopal, Moti; Crofoot, Gordon; Ruane, Peter; LaMarca, Anthony; Mills, Anthony; Vandercam, Bernard; de Wet, Joseph; Rockstroh, Jürgen; Lazzarin, Adriano; Rijnders, Bart; Podzamczer, Daniel; Thalme, Anders; Stoeckle, Marcel; Porter, Danielle; Liu, Hui C; Cheng, Andrew; Quirk, Erin; SenGupta, Devi; Cao, Huyen
Source
In The Lancet HIV May 2017 4(5):e195-e204
Subject
Language
ISSN
2352-3018